Renalytix partners with Tempus AI to expand kidney disease testing
Go back to Renalytix partners with Tempus AI to expand kidney disease testing| Oppenheimer Real Estate Fund Class N (NASDAQ: RENX) | Delayed: 1.88 -0.12 (6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.00 | 52 Week High | $18.34 | |||
| Open | $1.91 | 52 Week Low | $14.92 | |||
| Day High | $1.96 | P/E | N/A | |||
| Day Low | $1.87 | EPS | $0.00 | |||
| Volume | 26,306 | |||||
| (AMEX: RNLXY) | Delayed: 2.77 +0.13 (4.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.64 | 52 Week High | $ | |||
| Open | $2.64 | 52 Week Low | $ | |||
| Day High | $2.90 | P/E | N/A | |||
| Day Low | $2.64 | EPS | $ | |||
| Volume | 8,863 | |||||
| StemCells, Inc. (NASDAQ: TEM) | Delayed: 52.10 -2.19 (4.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.29 | 52 Week High | $0.45 | |||
| Open | $53.90 | 52 Week Low | $0.37 | |||
| Day High | $54.04 | P/E | N/A | |||
| Day Low | $51.76 | EPS | $-0.31 | |||
| Volume | 3,019,255 | |||||

